Press release
C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Clinical Trials 2024: FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight
C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Clinical Trials
Explore our latest breakthroughs in C-MET Non-Small Cell Lung Cancer Research. Learn more about our innovative pipeline today! @ C-MET Non-Small Cell Lung Cancer Pipeline Outlook- https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the C-MET Non-Small Cell Lung Cancer Pipeline Report
• June 2024:- AbbVie- A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer.
• May 2024: Apollomics Inc.- Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors.
• DelveInsight's C-MET Non-Small Cell Lung Cancer pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for C-MET Non-Small Cell Lung Cancer treatment.
• The leading C-MET Non-Small Cell Lung Cancer Companies such as Novartis, Apollomics Inc., Abbvie, Janssen Research and Development, and others.
• Promising C-MET Non-Small Cell Lung Cancer Therapies such as Glumetinib, Telisotuzumab vedotin, Tepotinib, APL-101 Oral Capsules, MCLA-129, Osimertinib, PLB1001, and others.
Stay informed about the cutting-edge advancements in C-MET Non-Small Cell Lung Cancer Treatments. Download for updates and be a part of the revolution in oncology care @ C-MET Non-Small Cell Lung Cancer Clinical Trials Assessment- https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
C-MET Non-Small Cell Lung Cancer Emerging Drugs Profile
• EGF-816 (Nazartinib): Novartis Oncology
Novarti's lead drug candidate, EGF-816 (Nazartinib), is small molecule in combination with INC280 is in development for the treatment of non-small cell lung cancer. Clinical trials data demonstrated that EGF-816 (Nazartinib) for the treatment of C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) has beneficial effects. The drug is a new molecule which is an epidermal growth factor receptor antagonist that blocks the function of protein EGFR.
• APL 101 (Bozitinib): Appolomics Inc.
Apollomics drug APL 101 (Bozitinib) is an orally administered small molecule currently being evaluated for the treatment of C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) and has demonstrated good safety and efficacy profile in phase II trials. APL 101 (Bozitinib) is an anti-neoplastics which inhibits the C-met protein.
Learn more about C-MET Non-Small Cell Lung Cancer Drugs opportunities in our groundbreaking C-MET Non-Small Cell Lung Cancer Research and development projects @ C-MET Non-Small Cell Lung Cancer Unmet Needs- https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration.
• Subcutaneous
• Intravenous
• Oral
• Intramuscular
• Molecule Type
C-MET Non-Small Cell Lung Cancer Products have been categorized under various Molecule types such as
• Small molecules
• Natural metabolites
• Monoclonal antibodies
• Product Type
Discover the latest advancements in C-MET Non-Small Cell Lung Cancer Treatment by visiting our website. Stay informed about how we're transforming the future of oncology @ C-MET Non-Small Cell Lung Cancer Market Drivers and Barriers, and Future Perspectives- https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the C-MET Non-Small Cell Lung Cancer Pipeline Report
• Coverage- Global
• C-MET Non-Small Cell Lung Cancer Companies- Novartis, Apollomics Inc., Abbvie, Janssen Research and Development, and others.
• C-MET Non-Small Cell Lung Cancer Therapies- Glumetinib, Telisotuzumab vedotin, Tepotinib, APL-101 Oral Capsules, MCLA-129, Osimertinib, PLB1001, and others.
• C-MET Non-Small Cell Lung Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• C-MET Non-Small Cell Lung Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
For a detailed overview of our latest research findings and future plans, read the full details of C-MET Non-Small Cell Lung Cancer Pipeline on our website @ C-MET Non-Small Cell Lung Cancer Drugs and Companies- https://www.delveinsight.com/sample-request/c-met-mutated-non-small-cell-lung-cancer-nsclc-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Introduction
2. Executive Summary
3. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC): Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) - DelveInsight's Analytical Perspective
7. In-depth Commercial Assessment
8. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Collaboration Deals
9. Late Stage Products (Phase III)
10. EGF 816 (Nazartinib): Novartis
11. Drug profiles in the detailed report…..
12. Mid Stage Products (Phase II)
13. APL 101 (Bozitinib): Apollomics Inc.
14. Drug profiles in the detailed report…..
15. Pre-clinical and Discovery Stage Products
16. Drug profiles in the detailed report…..
17. Inactive Products
18. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Key Companies
19. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Key Products
20. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)- Unmet Needs
21. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)- Market Drivers and Barriers
22. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC)- Future Perspectives and Conclusion
23. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Analyst Views
24. C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Key Companies
25. Appendix
Trending Reports:
• Hemophilia With Inhibitor Market: https://www.delveinsight.com/report-store/hemophilia-a2030-market
• Hemorrhagic Cystitis Market: https://www.delveinsight.com/report-store/hemorrhagic-cystitis-market
• Hepatic Encephalopathy Market: https://www.delveinsight.com/report-store/hepatic-encephalopathy-market
• Hepatitis D Market: https://www.delveinsight.com/report-store/hepatitis-d-market
• Hepatorenal Syndrome Market: https://www.delveinsight.com/report-store/hepatorenal-syndrome-market
• Hereditary Angioedema Market: https://www.delveinsight.com/report-store/hereditary-angioedema-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Hyperkalemia Market: https://www.delveinsight.com/report-store/hyperkalemia-market
• Hypoparathyroidism Market: https://www.delveinsight.com/report-store/hypoparathyroidism-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Intracranial Pressure Monitoring Devices Market: https://www.delveinsight.com/report-store/intracranial-pressure-monitoring-devices-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market-forecast
• Menorrhalgia Market Size: https://www.delveinsight.com/report-store/menorrhalgia-market
• Metastatic Bone Pain Market: https://www.delveinsight.com/report-store/metastatic-bone-pain-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Myelofibrosis Market: https://www.delveinsight.com/report-store/myelofibrosis-mf-market
• Necrotizing Enterocolitis Market: https://www.delveinsight.com/report-store/necrotizing-enterocolitis-market
• Neurotrophic Keratitis Market: https://www.delveinsight.com/report-store/neurotrophic-keratitis-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Neurovascular Thrombectomy Devices Market: https://www.delveinsight.com/report-store/neurovascular-thrombectomy-devices-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Oral Mucositis Om Market: https://www.delveinsight.com/report-store/oral-mucositis-om-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/rare-diseases
Case study: https://www.delveinsight.com/case-study/breast-cancer-market-dynamics-dashboard
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Clinical Trials 2024: FDA Approvals, Medication, Therapies, Treatment Market, MOA, ROA and Companies by DelveInsight here
News-ID: 3747966 • Views: …
More Releases from DelveInsight Business Research
Global Pharmaceutical Cartridges Market to grow at a CAGR of 7.39% to reach USD …
According to DelveInsight's analysis, The growth of the pharmaceutical cartridges market is largely fueled by the increasing prevalence of chronic diseases that require long-term and consistent medication use. Moreover, the rising trend of self-administered treatments and the growing preference for home-based healthcare are major contributors to market expansion. Technological advancements in drug delivery systems have further supported this growth by enhancing patient convenience, improving dosage precision, and promoting better treatment…
Global Nucleic Acid Amplification Testing Market to grow at a CAGR of 8.13% by 2 …
According to DelveInsight's analysis, The growing demand for Nucleic Acid Amplification Testing (NAAT) is primarily driven by the increasing prevalence of infectious and genetic diseases. Additionally, the rising incidence of cancer and the expanding R&D efforts by major industry players are further fueling market growth. Together, these factors are expected to support a strong upward trajectory for the NAAT market throughout the forecast period from 2025 to 2032.
DelveInsight's "Nucleic Acid…
Global Cardiac Mapping System Market to grow at a CAGR of 8.37% by 2032, Evaluat …
According to DelveInsight's analysis, The growing incidence of cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia, is driving the expansion of the cardiac mapping system market. These systems play a crucial role in the early detection and management of such conditions by providing real-time visualization of the heart's electrical activity, thereby reducing the risk of severe complications like stroke and heart failure. Moreover, the rising adoption of minimally invasive procedures,…
Global Graft Preparation System Market to grow at a CAGR of 4.17% to reach USD 3 …
According to DelveInsight's analysis, The demand for graft preparation systems is experiencing notable growth, primarily driven by the rising incidence of bone disorders and skin-related conditions. Moreover, the increasing number of surgical procedures worldwide, coupled with expanding R&D initiatives and strategic collaborations among leading market players, is further fueling market expansion. Together, these factors are expected to create a strong growth outlook for the graft preparation system market during the…
More Releases for Small
Succeeding Small Launches Small Business Give-Back Giveaway in Celebration of Sm …
Succeeding Small Launches Small Business Give-Back Giveaway in Celebration of Small Business Month
Honoring Local Colorado Springs Businesses That Make a Difference in Their Community
COLORADO SPRINGS, CO - Succeeding Small, a go-to guide for small business success in small business marketing, is celebrating Small Business Month with the launch of its Small Business Give-Back Giveaway - a contest aimed at honoring the small, service-based businesses that make a meaningful difference in…
Small Molecules, Big Impact: The Rise of the Small Molecule Immunomodulators Mar …
Small Molecule Immunomodulators Market worth $270.8 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Small Molecule Immunomodulators Market - (By Product (Disposable, Reusable), By Application (Colorectal, Thoracic, Orthopedic, Ophthalmology, Neurosurgery, Cardiac Surgery, Gynecology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to…
Powering Small: Small Gas Engines Market Advances (2023-2032)
"According to the research report, the global small gas engines market was valued at USD 2.75 billion in 2022 and is expected to reach USD 4.23 billion by 2032, to grow at a CAGR of 4.4% during the forecast period."
Polaris Market Research has recently published the latest update on Small Gas Engines Market: By Size, Latest Trends, Share, Huge Growth, Segments, Analysis and Forecast, 2030 that offers detailed market analysis,…
Small Batch Freeze Dryer Market: Increasing Demand for Small-scale Freeze Drying …
Global Small Batch Freeze Dryer Market Overview:
The Small Batch Freeze Dryer market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Small Batch Freeze Dryer market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and…
Global Small Gas Engines Market, Global Small Gas Engines Industry, Covid-19 Imp …
The Small Gas Engines market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Small Gas Engines Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Small Gas Engines market. The report focuses on well-known providers…
Small Appliances Market: Strategic Assessment of Emerging Technologies in Small …
Small appliances market is forecasted to grow substantially in all market segments through 2016 owing to the rise in living standards and need for more comfort. Small appliance industry consists of home appliances that are movable or partially movable and can be used on tables, counters, or other platforms. The growth of small appliances market is expected to be driven by product innovation, upgradation of existing products, and value-added features…
